CNMD EBITDA
Period ending:
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
CNMD ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 40 observations from Dec 31, 1986 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 176,485,000 | |
| 251,631,000 | |
| 172,003,000 | |
| 27,562,000 | |
| 179,333,000 | |
| 118,280,000 | |
| 146,249,000 | |
| 133,108,000 | |
| 105,483,000 | |
| 90,043,000 | |
| 95,054,000 | |
| 98,520,000 | |
| 104,112,000 | |
| 111,826,000 | |
| 47,058,000 | |
| 94,577,000 | |
| 66,524,000 | |
| 111,971,000 | |
| 112,525,000 | |
| 25,248,000 | |
| 94,534,000 | |
| 89,204,000 | |
| 112,709,000 | |
| 101,719,000 | |
| 99,106,000 | |
| 93,951,000 | |
| 100,500,000 | |
| 84,800,000 | |
| 32,800,000 | |
| 32,000,000 | |
| 23,800,000 | |
| 12,800,000 | |
| 1,400,000 | |
| 8,000,000 | |
| 8,200,000 | |
| 6,000,000 | |
| 1,300,000 | |
| 1,700,000 | |
| 2,200,000 | |
| 1,700,000 |
Compare ebitda
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) ebitda
- Bridgebio Pharma Inc (BBIO) ebitda
- Brightspring Health Services Inc (BTSG) ebitda
- Madrigal Pharmaceuticals Inc (MDGL) ebitda
- Ensign Group Inc (ENSG) ebitda
- Glaukos Corp (GKOS) ebitda
- Vaxcyte Inc (PCVX) ebitda
- Krystal Biotech Inc (KRYS) ebitda
All CNMD financial metrics · CNMD stock overview · How to interpret financial metrics